Catalyst

Slingshot members are tracking this event:

Phase 1b data of Nektar Therapeutics'(NKTR) NKTR-358 in Systemic lupus erythematosus (SLE) due at EULAR June 13, 2019

Source Link:
https://ir.nektar.com/news-releases/news-release-details/nektar-therapeutics-reports-financial-results-first-quarter-2019

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
Importance
High Medium Low
Impact on Stocks
NKTR Community voting in process
SIGN ME UP
I want to vote! LOG ME IN
Now!
Slingshot Insights Explained
JOIN FOR FREE TODAY
Catalyst Date
Occurred on:
Jun 13, 2019
Occurred Source:
https://ir.nektar.com/news-releases/news-release-details/first-human-data-presented-phase-1a-study-nktr-358-novel-t
Related Projects Image

  • Don’t see a project related to the catalyst you care about?

Related Keywords Nktr-358, Systemic Lupus Erythematous, Eular
About Us
Media Center
Connect with Us
© 2025 Slingshot Insights. All rights reserved.